Skip to Main Content

Paper Details

The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients.
Cancer Res
47
2015
ADCY8, GEM, NF1, Nf1, Nf1 GEM, adenylate, adenylate cyclase 8, cAMP, cyclic AMP, glioma, gliomagenesis, human, human adenylate cyclase, human adenylate cyclase gene, mouse, patients, therapeutic, tumor, type I neurofibromatosis
Author NameAffiliation
Amanda MerkelsonNew York University Langone Medical Center
Douglas R StewartClinical Genetics Branch, National Cancer Institute
Douglas R StewartClinical Genetics Branch, National Cancer Institute
Karlyne M ReillyCenter for Cancer Research, National Cancer Institute
Karlyne M ReillyCenter for Cancer Research, National Cancer Institute
Michael J FisherThe Children's Hospital of Philadelphia, The Perelman School of Medicine at the University of Pennsylvania
Uri TaboriThe Hospital for Sick Children, University of Toronto
Jeffrey C AllenNew York University Langone Medical Center
David H GutmannWashington University School of Medicine
Joshua B RubinWashington University School of Medicine
  • 1 - 10

Datasets

Release 1.2